Complete revascularization of multivessel coronary artery disease in patients with ST elevation acute coronary syndrome – for whom and when? A comprehensive review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F23%3A10157627" target="_blank" >RIV/00098892:_____/23:10157627 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61989592:15110/23:73613366

Výsledek na webu

<a href="https://biomed.papers.upol.cz/artkey/bio-202301-0003_complete-revascularization-of-multivessel-coronary-artery-disease-in-patients-with-st-elevation-acute-coronary.php" target="_blank" >https://biomed.papers.upol.cz/artkey/bio-202301-0003_complete-revascularization-of-multivessel-coronary-artery-disease-in-patients-with-st-elevation-acute-coronary.php</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5507/bp.2022.024" target="_blank" >10.5507/bp.2022.024</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Complete revascularization of multivessel coronary artery disease in patients with ST elevation acute coronary syndrome – for whom and when? A comprehensive review

Popis výsledku v původním jazyce

Atherosclerosis is the most common cause of coronary steno-occlusive disease and acute myocardial infarction is the leading cause of death in industrialized countries. In patients with acute ST elevation myocardial infarction (STEMI), there is unquestionable evidence that primary percutaneous coronary intervention providing recanalization of the infarct related artery (IRA) is the preferred reperfusion strategy. Nevertheless, up to 50% of patients with STEMI have multivessel coronary artery disease defined as at least 50% stenosis exclusive of IRA. There is conflicting data regarding the optimal treatment strategy and timing in such patients. Currently, it is assumed that stable patients might benefit from complete revascularization particularly in reducing the need for future unplanned procedures but only culprit lesion should be treated during index procedure in unstable patients. In this article, we provide a comprehensive overview of this important and currently highly debated topic.

Název v anglickém jazyce

Complete revascularization of multivessel coronary artery disease in patients with ST elevation acute coronary syndrome – for whom and when? A comprehensive review

Popis výsledku anglicky

Atherosclerosis is the most common cause of coronary steno-occlusive disease and acute myocardial infarction is the leading cause of death in industrialized countries. In patients with acute ST elevation myocardial infarction (STEMI), there is unquestionable evidence that primary percutaneous coronary intervention providing recanalization of the infarct related artery (IRA) is the preferred reperfusion strategy. Nevertheless, up to 50% of patients with STEMI have multivessel coronary artery disease defined as at least 50% stenosis exclusive of IRA. There is conflicting data regarding the optimal treatment strategy and timing in such patients. Currently, it is assumed that stable patients might benefit from complete revascularization particularly in reducing the need for future unplanned procedures but only culprit lesion should be treated during index procedure in unstable patients. In this article, we provide a comprehensive overview of this important and currently highly debated topic.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Biomedical Papers

ISSN

1213-8118

e-ISSN

1804-7521

Svazek periodika

167

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

8

Strana od-do

16-23

Kód UT WoS článku

000812127800001

EID výsledku v databázi Scopus

2-s2.0-85150396806